Scientific Letters
Vol. 18 No. 1 (2026): Mediterranean Journal of Hematology and Infectious Diseases
Late-onset anicteric veno-occlusive disease after haploidentical HSCT: diagnostic challenges in the setting of CMV reactivation
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 30, 2026
0
Views
0
Downloads
0
HTML
Authors
Downloads
Download data is not yet available.
Citations
References
1. Song Z, Han X, Zhou Z, et al. Comprehensive management of hematopoietic stem cell transplantation complications: from infection prevention to immune microenvironment reconstruction. Front Immunol. 2026;17:1740067.
2. Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, et al. Diagnosis and treatment of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489.
3. Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51:906–912.
4. Corbacioglu S, Kernan NA, Pagliuca A, Ryan RJ, Tappe W, Richardson PG. Incidence of anicteric veno-occlusive disease/sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric patients. Biol Blood Marrow Transplant. 2020;26:1342–1349.
5. Limaye AP, Babu TM, Boeckh M. Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation. Clin Microbiol Rev. 2020;34:e00043-19.
6. Lee SB, Lee S, Cho YJ, Choi YH, Cheon JE, Hong KT, et al. Shear wave elastography and dispersion imaging for hepatic veno-occlusive disease prediction after pediatric hematopoietic stem cell transplantation: a feasibility study. Pediatr Radiol. 2024;54:1144–1155.
7. Cairo MS, Cooke KR, Lazarus HM, Chao N. Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation. Br J Haematol. 2020;190:822–836.
8. Richardson PG, Corbacioglu S. Veno-occlusive disease/sinusoidal obstruction syndrome in patients: survival after defibrotide treatment. Blood Cancer J. 2020;10:29.
9. Mehra V, Tetlow S, Choy A, de Lavallade H, Kulasekararaj A, Krishnamurthy P, et al. Early and late-onset veno-occlusive disease/sinusoidal obstruction syndrome post allogeneic stem cell transplantation: a real-world experience. Am J Transplant. 2021;21:864–869.
Supporting Agencies
NoneHow to Cite
“Late-onset anicteric veno-occlusive disease after haploidentical HSCT: diagnostic challenges in the setting of CMV reactivation” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026057. doi:10.4084/MJHID.2026.057.
Copyright (c) 2026 Thi Tuyet Mai Nguyen, Tuan Tung Nguyen, Van Tuan Ta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
